Long-term results from a randomized trial confirmed that early rituximab monotherapy for advanced-stage, asymptomatic, low ...

IGI, a global, fully integrated clinical-stage biotechnology company focused on developing multispecifics™ in oncology, today announced ...

IO Biotech's first-in-class vaccine performs double duty, killing cancer cells and enhancing the tumor microenvironment. A ...

Good day everyone and welcome to today’s first-quarter 2025 Kura Oncology financial results conference call. (Operator Instructions) Please note this call may be recorded and I will be standing by if ...

The United Kingdom aims to boost its life sciences profile as Aviva Capital Partners and Socius unveiled plans for a £1 ...

AMGN beats first-quarter estimates for earnings and sales. Sales of most of its products, Prolia, Xgeva, Repatha, Blincyto and Evenity beat estimates.